XETRA - Delayed Quote EUR
Pfizer Inc. (PFE.DE)
20.04
+0.35
+(1.78%)
At close: 5:35:36 PM GMT+2
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BLAYLOCK RONALD E Director | Purchase | Feb 13, 2025 | 32,457 |
| BOSHOFF CHRISTOFFEL Officer | Stock Award(Grant) | Feb 27, 2025 | 163,902 |
| BOURLA ALBERT Chief Executive Officer | Conversion of Exercise of derivative security | Feb 27, 2025 | 372,946 |
| DAMICO JENNIFER B. Officer | Stock Award(Grant) | Mar 4, 2025 | 11,850 |
| FONSECA LIDIA PH.D. Officer | Conversion of Exercise of derivative security | Feb 27, 2025 | 41,829 |
| GOTTLIEB SCOTT Director | Purchase | Oct 30, 2024 | 10,000 |
| LANKLER DOUGLAS M Officer | Conversion of Exercise of derivative security | Feb 27, 2025 | 161,191 |
| MCDERMOTT MICHAEL Officer | Conversion of Exercise of derivative security | Feb 27, 2025 | 75,958 |
| SAHNI PAYAL Officer | Conversion of Exercise of derivative security | Feb 27, 2025 | 38,866 |
| SUSMAN SALLY Officer | Conversion of Exercise of derivative security | Feb 27, 2025 | 169,775 |
Related Tickers
JNJ.DE Johnson & Johnson
136.32
-0.16%
4AB.DE AbbVie Inc.
158.40
+2.33%
LLY.DE Eli Lilly and Company
746.80
+3.19%
IDP.DE Biogen Inc.
105.50
+1.49%
6MK.DE Merck & Co., Inc.
68.90
-0.58%
GLAXO.BO GlaxoSmithKline Pharmaceuticals Limited
2,916.75
+2.31%
LLY.F Eli Lilly and Company
757.00
+3.88%
NOVA.F Novo Nordisk A/S
54.50
+0.37%
NNO2.VI Novo Nordisk A/S
54.95
+0.53%
NOV.F Novo Nordisk A/S
55.10
+1.40%